A rare genetic variant in the F2 gene has been linked to atypical hemolytic uremic syndrome and severe kidney damage in a postpartum Chinese woman, ahusnews.com reported.
The 31-year-old patient developed the condition shortly after childbirth, despite genetic testing revealing no known complement-system mutations. Researchers detailed the case in BMC Nephrology, exploring whether coagulation gene variations can drive severe pregnancy-related kidney complications.
A Genetic Variant Causes Kidney Failure After Childbirth
- What happened: A new genetic variant in a blood-clotting gene was linked to a rare, dangerous form of kidney failure after childbirth.
- The mechanism: The complement immune system became dangerously overactive, forming small blood clots in kidney blood vessels.
- The outcome: After plasma exchange and targeted blood-thinner therapy, the patient recovered kidney function and maintained stability over a six-year follow-up.
The F2 Variant Triggers Microvascular Blood Clots During Pregnancy
In atypical hemolytic uremic syndrome, or aHUS, the complement cascade becomes hyperactive and creates microvascular blood clots. Pregnancy is a recognized clinical trigger for the condition, which typically relies on underlying mutations in complement regulatory genes.
The patient presented with a history of gestational hypertension and HELLP syndrome, which involves red blood cell destruction, low platelets, and liver stress. Moments after her placenta was delivered at 38 weeks, she experienced a sharp drop in blood pressure and oxygen levels.
Doctors initially diagnosed an amniotic fluid embolism complicated by intravascular coagulation. Despite mechanical ventilation, blood transfusions, and intensive care stabilization, her condition deteriorated rapidly the following day. She stopped producing urine, developed seizures, and suffered a dramatic spike in creatinine levels.
Clinical Intervention and Plasma Exchange Protocols
Laboratory blood tests revealed schistocytes, which are fragmented red blood cells indicative of physical damage inside narrow blood vessels. A kidney biopsy confirmed dead tissue in the renal filtering units alongside microvascular clots, leading clinicians to suspect aHUS.
Medical teams initiated plasma exchange therapy three times weekly to replace patient plasma with fresh donor plasma. She also received alprostadil and the blood thinner rivaroxaban.
After 10 plasma exchange sessions, red blood cell destruction slowed, while platelet counts and complement protein activity normalized. Her renal recovery allowed clinicians to halt dialysis entirely.
Genetic sequencing revealed no mutations in classical complement regulatory genes. Instead, tests identified a distinct variant designated as c.593G>A within one copy of the F2 gene.
Experiments on lab-grown human endothelial cells demonstrated that this F2 variant upregulated specific complement-coding genes. Researchers suggested that the alteration enhances thrombin activity, creating a direct bridge between the coagulation system and complement hyperactivation.
| Clinical Parameter | Initial Presentation | Post-Treatment Status |
|---|---|---|
| Renal Function (Creatinine) | Tripled baseline, anuria | Normalized, dialysis halted |
| Platelet Count | Severe thrombocytopenia | Returned to normal levels |
| Complement Activity | Abnormally depleted | Restored to baseline |
Seek Emergency Care for Postpartum Hypertension or Seizures
Anyone experiencing sudden postpartum hypertension, rapid drops in urine output, or neurological symptoms like seizures must seek emergency medical intervention.
Long-Term Prognosis and Future Research Directions
Following discharge, the patient maintained long-term rivaroxaban therapy due to a suspected hypercoagulable state. Over six years of continuous clinical follow-up, her renal function remained stable.
Investigators concluded that this non-complement variant demands broader diagnostic horizons in atypical hemolytic uremic syndrome cases. Exploring coagulation-complement crosstalk may reshape how clinicians evaluate postpartum renal failure.
References
- BMC Nephrology. Pregnancy-associated aHUS with a non-complement variant: a case report. Can a coagulation gene variant dictate prognosis?
